Here's the live share price of Jubilant Pharmova along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Jubilant Pharmova has gained 8.10% CAGR. Over the past year, the corresponding return has been -5.72%.
Jubilant Pharmova’s current P/E of 38.96x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Jubilant Pharmova | 5.22 | 4.49 | 2.87 | 29.88 | -5.72 | 50.33 | 8.10 |
Sun Pharmaceutical Industries | 0.49 | -2.26 | -5.11 | -4.83 | -13.57 | 21.68 | 26.44 |
Divi's Laboratories | 0.52 | -1.02 | -9.43 | 7.50 | 9.92 | 18.00 | 13.79 |
Cipla | -0.28 | -0.82 | 2.90 | 5.98 | -6.64 | 13.52 | 16.50 |
Torrent Pharmaceuticals | -1.37 | -2.40 | 8.62 | 15.45 | 2.18 | 32.67 | 20.35 |
Dr. Reddy's Laboratories | 2.63 | 3.94 | -4.38 | 17.51 | -2.24 | 15.26 | 8.32 |
Mankind Pharma | 1.08 | 4.60 | 8.27 | 17.17 | 3.21 | 21.89 | 12.61 |
Zydus Lifesciences | 2.22 | 4.82 | 6.33 | 17.47 | -7.31 | 40.26 | 22.98 |
Lupin | 5.26 | 2.90 | 2.32 | 3.95 | -9.17 | 44.83 | 16.16 |
Abbott India | -0.65 | -6.10 | -1.81 | 4.61 | 4.78 | 19.99 | 13.39 |
Alkem Laboratories | 2.90 | 1.86 | 13.26 | 16.73 | -13.69 | 19.58 | 13.54 |
Aurobindo Pharma | 5.19 | 2.00 | -4.52 | 0.37 | -29.92 | 25.72 | 6.67 |
Glenmark Pharmaceuticals | 2.18 | 3.28 | 25.67 | 49.43 | 19.74 | 74.71 | 34.18 |
Laurus Labs | 1.69 | 3.76 | 34.34 | 56.24 | 77.17 | 17.47 | 27.44 |
Biocon | -1.47 | -0.49 | 0.84 | 11.01 | -5.37 | 5.74 | -3.58 |
Anthem Biosciences | 0.60 | 10.61 | 14.29 | 14.29 | 14.29 | 4.55 | 2.71 |
GlaxoSmithKline Pharmaceuticals | -0.66 | -0.78 | -16.58 | 3.56 | -5.20 | 24.76 | 9.75 |
Cohance Lifesciences | 6.64 | -0.16 | -1.94 | -14.02 | -18.42 | 26.86 | 22.11 |
Ipca Laboratories | -1.64 | -3.72 | -3.93 | 1.15 | -11.03 | 13.54 | 4.09 |
Gland Pharma | 5.95 | 2.86 | 18.75 | 29.08 | 6.84 | -6.26 | 1.96 |
Over the last one year, Jubilant Pharmova has declined 5.72% compared to peers like Sun Pharmaceutical Industries (-13.57%), Divi's Laboratories (9.92%), Cipla (-6.64%). From a 5 year perspective, Jubilant Pharmova has underperformed peers relative to Sun Pharmaceutical Industries (26.44%) and Divi's Laboratories (13.79%).
Day | SMA | EMA |
---|---|---|
5 | 1,109.92 | 1,114.71 |
10 | 1,076.52 | 1,098.66 |
20 | 1,071.1 | 1,092.65 |
50 | 1,131.16 | 1,102.63 |
100 | 1,088.46 | 1,086.73 |
200 | 1,040.39 | 1,039.77 |
In the latest quarter, Jubilant Pharmova saw a drop in promoter holding to 47.68%, while DII stake increased to 9.52%, FII holding rose to 17.40%, and public shareholding moved up to 24.83% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Quant Small Cap Fund | 29,47,185 | 1.05 | 301.53 |
Kotak Multicap Fund | 18,00,000 | 0.96 | 184.16 |
Bandhan Small Cap Fund | 15,35,656 | 1.08 | 157.11 |
Bandhan Focused Equity Fund | 5,97,755 | 3.19 | 61.16 |
Kotak India EQ Contra Fund - Regular Plan | 5,78,400 | 1.32 | 59.18 |
Aditya Birla Sun Life Small Cap Fund | 2,44,236 | 0.52 | 24.99 |
Nippon India Nifty Smallcap 250 Index Fund | 99,014 | 0.41 | 10.13 |
Aditya Birla Sun Life Pharma & Healthcare Fund | 94,886 | 1.15 | 9.71 |
Aditya Birla Sun Life Bal Bhavishya Yojna | 90,213 | 0.83 | 9.23 |
UTI Healthcare Fund | 89,675 | 0.82 | 9.17 |
Date Time | Announcement |
---|---|
Sep 13, 2025, 1:32 AM IST | Jubilant Pharmova - Reminder Email Sent To Shareholders Intimating About The 100 Days Campaign |
Sep 01, 2025, 7:25 PM IST | Jubilant Pharmova - Announcement under Regulation 30 (LODR)-Change in Management |
Aug 30, 2025, 3:17 AM IST | Jubilant Pharmova - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
Aug 30, 2025, 3:14 AM IST | Jubilant Pharmova - Shareholder Meeting / Postal Ballot-Outcome of AGM |
Aug 06, 2025, 5:09 AM IST | Jubilant Pharmova - Intimation Regarding A Letter Dispatched To The Shareholders For Annual Report Of The Company For FY 202 |
Jubilant Pharmova Ltd. is a Public Limited Listed company incorporated on 21/06/1978 and has its registered office in the State of Uttar Pradesh, India. Company's Corporate Identification Number(CIN) is L24116UP1978PLC004624 and registration number is 004624. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 745.70 Cr. and Equity Capital is Rs. 15.90 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Jubilant Pharmova is ₹1,125.50 as on Sep 15, 2025.
The Jubilant Pharmova is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Jubilant Pharmova is ₹17,927.09 Cr as on Sep 15, 2025.
Today’s highest and lowest price of Jubilant Pharmova are ₹1,128.65 and ₹1,107.05.
The 52-week high/low is the highest and lowest price at which Jubilant Pharmova stock has traded in the past 52-week or nearly a year. The 52-week high of Jubilant Pharmova is ₹1,309.00 and 52-week low of Jubilant Pharmova is ₹823.70 as on Sep 15, 2025.
The Jubilant Pharmova has shown returns of 0.25% over the past day, 4.49% for the past month, 2.87% over 3 months, -5.72% over 1 year, 50.33% across 3 years, and 8.1% over 5 years.
P/E ratio of and PB ratio of Jubilant Pharmova are 38.96 and 3.02 on Sep 15, 2025. While the company gives a dividend yield of 0.44 per annum.